Glycomics/Glycobiology Market Size, Share and Industry research 2019 to 2026

Glycomics/Glycobiology Market (By Product: Reagents, Kits, Enzymes, Instruments; By Application: Diagnostics, Drug Discovery & Development, Others; By End Use: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

A growing emphasis on studies into glycomics and proteomics resulted in this market growth. Academic scientists have also been able to create fresh instruments through significant investments in this sector. The field of glycoscience is thus increasing, which makes the industry a strong impact driver. In biodiversity procedures, glycans are crucial and study helps to more comprehensively understand biology, without specializing in glycobiology. The average R&D expenses of medium-sized biotech businesses rose about 14 percent from 2016 to 2017, according to BDO Biotech Briefing 2018.

The increased discovery and development of drugs leads to increased investment in R&D by biotechnology firms. Thus, there is a continually growing need for glycomic research methods to carry out an extensive glycomic study. The enhanced need for glycomic methods has resulted in an enhanced amount of Government projects to raise financing for R&D. Investments in science and innovations for the period 2017-2018 were approximately $10.4 billion by the government of Australia. In 2015, the Irish Government announced a USD 5.6 billion expenditure program to increase from 25,000 to 40,000 science studies.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1503

Such financing projects should increase demand for research methods for glycomics in the near future. Key businesses also undertake comprehensive R&D projects to create fresh and advanced technology goods. Shimadzu Corp., for example, collaborated with PREMIER Biosoft in 2018 to present its mass spectrometry scheme for advanced evaluation of glycomics and lipidomics in LCMS-9030 Quadrupole Flight Time (quadrupole time of vol) mass spectrometry. In addition, Gly-Q Glycan Analysis System, an embedded platform for user-friendly, high-performance glycoanalysis, has been introduced in 2016 by proZyme, inc.

Key Findings

Because of its broad implementation in research and diagnostics and repetitive purchases of such products, Enzymes are anticipated to be the world’s fastest-growing market for glycobiology.

Due to a strong demand for personalized drugs and a concentrate on new drug development, drug discovery & growth accounted for the biggest income share in the application segment in 2018.

North America was in 2018 the world market leader in glycomics and glycobiology and will continue its domination over the projected era.

The regional market is driven mainly by the presence of numerous North American study laboratories and pharmaceutical and biotechnological enterprises.

As the amount of drug and biopharmaceutical businesses in the region increases, Europe is anticipated to register its largest CA GR from 2019 to 2026.

Browse all official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases

Key Players & Strategies

Agilent Technologies, Thermo Fisher Scientifical, Inc., Takara Bio, Inc., Merck KGaA, Bruker, Shimadzu Corporation, Biolabs, Danaher, and ProZyme are among the main businesses on the market. Most of these businesses have a wide product range and powerful regional presence.

The main strategies conducted by these businesses for sustainable growth are new product launches, mergers and acquisitions, alliances and collaborations. Merck KGaA spent, for example, EUR 40 million in February 2018 to improve its facilities in the Asian region for distribution and manufacture.

In another case, Agilent Technologies acquired ULTRA Scientific Assets, which distributes accredited chemical products and norms, in July 2018. The objective of this purchase was to offer the business alternatives for life-science and to establish a broader consumer base.

Glycomics is a comparatively new technology and its innovative applications are being researched. Major market participants in glycomics therefore collaborate in the growth of newer technology with the educational institutions. In cooperation with the University of Southern California, for example, Agilent Technologies has facilitated scientists in the diagnostic sector, in fresh drug growth and in medical devices.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Glycomics/Glycobiology
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Glycomics/Glycobiology Market By Product
1.2.2.1. Global Glycomics/Glycobiology Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Glycomics/Glycobiology Market Revenue Share By Product in 2017
1.2.2.3. Reagents
1.2.2.4. Kits
1.2.2.5. Enzymes
1.2.2.6. Instruments
1.2.3. Glycomics/Glycobiology Market By Application
1.2.3.1. Global Glycomics/Glycobiology Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Diagnostics
1.2.3.3. Drug Discovery & Development
1.2.3.4. Others
1.2.4. Glycomics/Glycobiology Market By End Use
1.2.4.1. Global Glycomics/Glycobiology Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.2.4.2. Pharmaceutical & Biotechnology Companies
1.2.4.3. Academic & Research Institutes
1.2.4.4. CROs
1.2.5. Glycomics/Glycobiology Market by Geography
1.2.5.1. Global Glycomics/Glycobiology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Glycomics/Glycobiology Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Glycomics/Glycobiology Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Glycomics/Glycobiology Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Glycomics/Glycobiology Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Glycomics/Glycobiology Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Glycomics/Glycobiology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Glycomics/Glycobiology Major Manufacturers in 2017
3.3. R&D Status and Technology Product of Global Glycomics/Glycobiology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Glycomics/Glycobiology Major Manufacturers in 2017

CHAPTER 4. GLYCOMICS/GLYCOBIOLOGY MARKET BY PRODUCT

4.1. Global Glycomics/Glycobiology Revenue By Product
4.2. Reagents
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Kits
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Enzymes
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Instruments
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. GLYCOMICS/GLYCOBIOLOGY MARKET BY APPLICATION

5.1. Global Glycomics/Glycobiology Revenue By Application
5.2. Diagnostics
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Drug Discovery & Development
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. GLYCOMICS/GLYCOBIOLOGY MARKET BY END USE

6.1. Global Glycomics/Glycobiology Revenue By End Use
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Academic & Research Institutes
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

7.1. North America Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Glycomics/Glycobiology Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 8. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

8.1. Europe Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

9.1. Asia-Pacific Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 10. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

10.1. Latin America Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 11. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

11.1. Middle East Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 12. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

12.1. Africa Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 – 2026 ($Million)
12.2. Africa Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Agilent Technologies
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Takara Bio, Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Merck KGaA
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bruker
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Shimadzu Corporation
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Biolabs
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Danaher
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. ProZyme
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1503

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1503

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.